Last reviewed · How we verify

NCT06343467

Do Generic Volar Locking Plates Provide Similar Outcomes at a Reduced Cost?

Completed NA Results posted Last updated 28 August 2024
What this trial tests

NA trial testing Generic Volar Locking Plate in Distal Radius Fractures in 101 participants. Completed in 30 April 2023.

Timeline
1 November 2022
Primary endpoint
30 April 2023
30 April 2023

Quick facts

Lead sponsorHealthPartners Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment101
Start date1 November 2022
Primary completion30 April 2023
Estimated completion30 April 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

HealthPartners Institute

Who can join

18 and older, any sex, with Distal Radius Fractures. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

90-day Reoperation Rate Primary · Within 90 days postoperatively

Reoperation for any reason postoperatively within 90 days after the date of surgery.

GroupValue95% CI
Generic Implant0
Conventional Implant0
90-day Readmission Rate Primary · Within 90 days postoperatively

Readmission to the hospital for any reason postoperatively within 90 days after the date of surgery.

GroupValue95% CI
Generic Implant0
Conventional Implant0
90-day Mortality Rate Primary · Within 90 days postoperatively

Patient death at any point within 90 days after the date of surgery.

GroupValue95% CI
Generic Implant0
Conventional Implant0
Implant Cost Secondary · Day of Surgery

The total cost of implants used in the procedure, including screws, pegs, volar locking plates, and disposable implants.

GroupValue95% CI
Generic Implant702.38± 47.83
Conventional Implant1348.61± 100.77
Tourniquet Time Secondary · From tourniquet inflation to deflation during the procedure.

The total time in minutes from tourniquet inflation to deflation for a surgical case.

GroupValue95% CI
Generic Implant49.05± 19.2
Conventional Implant45.06± 12.84
Estimated Blood Loss Secondary · Day of Surgery

Estimated blood loss for the surgical case as reported by the surgeon in milliliters.

GroupValue95% CI
Generic Implant13.3± 10.2
Conventional Implant13.2± 6.8

Sponsor's own description

Across orthopedics, the investigators will be using the generic volar locking plates for patients undergoing open reduction and internal fixation (ORIF) of the distal radius using a block schedule, meaning one month we the generic implants and one month we use conventional implants from the surgeon's brand of choice. At the end of each month the health system will switch which type of implants (generic vs. conventional) they will use at their facilities. From a quality perspective each patient will be monitored both short and long term for complication and reoperation. This will be done through chart review.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Generic Volar Locking Plate Use in Distal Radius Fractures: A Prospective Randomized Study to Evaluate Clinical Outcomes and Cost Reduction.
    Doxey SA, Kleinsmith RM, Qian LJ, Husband JB, et al · · 2026 · PMID 39506267 · DOI 10.1177/15589447241293168

Verify or expand the search:

Other recruiting trials for Distal Radius Fractures

Currently open trials in the same condition.

Other HealthPartners Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06343467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing